| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6054981 | Oral Oncology | 2014 | 6 Pages | 
Abstract
												Non-cutaneous HNC is rare in transplant recipients, but slightly more common after liver transplantation. Outcome after treatment is poor with locoregional recurrence being the main problem. Screening of high risk groups might be relevant.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Dentistry, Oral Surgery and Medicine
												
											Authors
												Charlotte Nelissen, Maarten Lambrecht, Frederik Nevens, Dirk Van Raemdonck, Johan Vanhaecke, Dirk Kuypers, Jacques Pirenne, Sandra Nuyts, 
											